Latest S-1 registration statements

Ontrak files for registration of up to 51,622,216 shares of common stock issuable upon the exercise of outstanding warrants, as the company navigates Nasdaq listing requirements.

Rubber Leaf Inc has filed an amendment to its Form S-1 registration statement for a proposed public offering of 1,600,000 shares of common stock and a resale offering of 2,400,000 shares by selling stockholders.

Inhibikase Therapeutics is planning a best-efforts public offering of common stock and accompanying warrants, along with pre-funded warrants for certain investors.

ENDRA Life Sciences is launching a firm commitment public offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants to raise capital for working capital and general corporate purposes.

Yoshiharu Global Co. is registering for resale up to 237,885 shares of its Class A common stock by Alumni Capital LP, a selling stockholder, with the company planning to use any proceeds for working capital and general corporate purposes.

AIM ImmunoTech intends to offer up to 9,975,000 shares of common stock through an equity line of credit with Atlas Sciences, LLC, potentially raising up to $15 million.

Cyclacel Pharmaceuticals is seeking to raise up to $10 million through a public offering of common stock, warrants, and pre-funded warrants to bolster working capital.

RiceBran Technologies has filed a registration statement for the resale of up to 7,232,428 shares of common stock, including shares underlying warrants, by selling shareholders.

Q32 Bio Inc. is registering for resale up to 1,682,045 shares of its common stock by selling stockholders after completing its merger with Homology Medicines.

GP-Act III Acquisition Corp., a blank check company, files for a $250 million IPO to target high-potential businesses in the United States.

Spyre Therapeutics aims to register the resale of up to 33.4 million shares of its common stock by selling stockholders after recent private placements.

GCT Semiconductor Holding, Inc. has filed a registration statement for the issuance of common stock upon warrant exercises and the resale of common stock and private placement warrants by selling securityholders.

Barnes & Noble Education is launching a rights offering to raise up to $45 million, aiming to improve liquidity and address going concern doubts.

Panbela Therapeutics is undertaking a firm commitment public offering of common stock and warrants, alongside a proposed reverse stock split, to meet listing requirements for the US Equity Listings Tier II of the CBOE.

Virpax Pharmaceuticals launches a best efforts offering of common stock and warrants, aiming to raise up to $14 million to support product development, settle legal obligations, and bolster working capital.

VNUE, Inc. has filed a registration statement for the resale of up to 900 million shares of its common stock by selling stockholder GHS Investments, LLC, under an amended equity financing agreement.

MultiSensor AI Holdings seeks to register the resale of existing shares and warrants, potentially generating significant capital through warrant exercises.

AFB Limited files an amendment to its S-1 registration statement, addressing SEC comments related to risks associated with operating in Hong Kong and potential regulatory interventions.

Zeo Energy Corp. is registering for the resale of shares and warrants following its recent business combination, potentially impacting the stock's market price.

Dror Ortho-Design, Inc. files an amendment to its S-1 registration statement to register the resale of over 2.3 billion shares of common stock by selling securityholders.

Invech Holdings, Inc. files an amendment to its S-1 registration statement for the resale of up to 3,277,416 shares of common stock by selling stockholders.

Invizyne Technologies seeks to go public, planning to use proceeds to expand its SimplePath biomanufacturing platform for pharmaceuticals and biofuels.

TriLinc Global Impact Fund is offering existing unitholders the opportunity to reinvest their distributions to purchase additional units, aiming to raise up to $40 million.

OneMedNet Corporation files an amendment to its S-1 registration statement for a primary offering of common stock upon warrant exercise and a secondary offering of common stock and warrants by selling securityholders.

Maitong Sunshine Cultural Development Co., Limited files Amendment No. 5 to its Form S-1 registration statement with the SEC, primarily as an exhibit-only filing.

Allarity Therapeutics is offering 5,000,000 shares of common stock at an assumed price of $2.00 per share to raise capital while facing potential delisting from the Nasdaq Capital Market.

Nuwellis, Inc. is undertaking a best efforts offering of common stock and warrants to raise approximately $4.3 million for working capital and general corporate purposes.

Loar Group Inc. enters into a master agreement to purchase term loans in the open market, contingent on IPO completion and receipt of effective date statements.

Applied UV, Inc. has filed a registration statement for the potential resale of up to 518,065 shares of its common stock by selling stockholders, which are issuable upon the exercise of warrants issued in a private placement.

Silvaco Group, Inc. files an amendment to its S-1 registration statement, outlining details for its proposed initial public offering and a concurrent resale prospectus.